Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) – Equities researchers at HC Wainwright cut their FY2023 earnings estimates for shares of Terns Pharmaceuticals in a research note issued to investors on Thursday, November 16th. HC Wainwright analyst E. Arce now anticipates that the company will post earnings per share of ($1.27) for the year, down […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given an average rating of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average recommendation of “Moderate Buy” from the nine analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month price objective […]
Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month target price among […]
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $10.00 to $11.00 in a report published on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other research analysts have also recently issued research reports about the stock. Roth Mkm […]